- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Avacta Group PLC (AVCT)
London
Currency in GBP
Disclaimer
72.90
+1.40(+1.96%)
Closed
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
70.65
73.00
52 wk Range
39.50
166.98
AVCT Scorecard
Full Analysis
High shareholder yield
Avacta Group PLC stock price live, this page displays LON AVCT stock exchange data. View the AVCT premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Avacta Group PLC real time stock price chart below.
What Is the Avacta Group PLC Stock Price Today?
The Avacta Group PLC stock price today is 72.90.
What Is the Stock Symbol for Avacta Group PLC?
The stock symbol for Avacta Group PLC is "AVCT."
What Stock Exchange Does Avacta Group PLC Trade On?
Avacta Group PLC is listed and trades on the London stock exchange.
Is Avacta Group PLC a Good Stock to Buy?
Determining whether Avacta Group PLC—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the AVCT quote. (ISIN: GB00BYYW9G87)
What Is the Avacta Group PLC Stock Price Today?
The Avacta Group PLC stock price today is 72.90.
What Is the Stock Symbol for Avacta Group PLC?
The stock symbol for Avacta Group PLC is "AVCT."
What Stock Exchange Does Avacta Group PLC Trade On?
Avacta Group PLC is listed and trades on the London stock exchange.
Is Avacta Group PLC a Good Stock to Buy?
Determining whether Avacta Group PLC—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the AVCT quote. (ISIN: GB00BYYW9G87)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
70.6573.00
52 wk Range
39.50166.98
UnlockAVCT Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Price Target
109.33
Upside
+49.97%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Net income is expected to drop this year
Avacta Group PLC Company Profile
Avacta Group Plc develops cancer drugs and in vitro diagnostics in the United Kingdom, France, North America, South Korea, rest of Europe, and internationally. The company operates through Diagnostics and Therapeutics segments. It provides its proprietary Affimer and pre|CISION technology platforms, which is used to deliver a portfolio of differentiated th therapeutic and diagnostic products that addresses various markets. The company develops AVA6000, a peptide drug conjugate form of doxorubicin that is in Phase I clinical trial to treat locally advanced or metastatic solid tumour; AVA3996, a tumor-activated proteasome inhibitor based on Velcade; and AVA032, a bispecific molecule which is in pre-clinical trials that regulates the activation and proliferation of immune cells. It develops AVA-028-PD-L1 Affimer/ImmunoCytokines; AVA-021 - PD-L1 Affimer/LAG-3 Affimer; and TMAC platform that utilizes the proprietary pre|CISION substrate to provide for the selective release of a drug moiety by FAPa. The company has a collaboration agreement with LG Chem for developing and commercializing Affimer based therapeutics. Avacta Group Plc was incorporated in 2003 and is based in Wetherby, the United Kingdom.
Compare AVCT to Peers and Sector
Metrics to compare | AVCT | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipAVCTPeersSector | |
|---|---|---|---|---|
P/E Ratio | −10.5x | −4.6x | −0.6x | |
PEG Ratio | −0.29 | −0.23 | 0.00 | |
Price/Book | 12.0x | 1.6x | 2.6x | |
Price / LTM Sales | 11.3x | 23.1x | 3.1x | |
Upside (Analyst Target) | 37.2% | 87.5% | 58.1% | |
Fair Value Upside | Unlock | 18.6% | 9.2% | Unlock |
People Also Watch
FAQ
What Is the Avacta Group (AVCT) Stock Price Today?
The Avacta Group stock price today is 72.90
What Stock Exchange Does Avacta Group Trade On?
Avacta Group is listed and trades on the London stock exchange.
What Is the Stock Symbol for Avacta Group?
The stock symbol for Avacta Group is "AVCT."
What Is the Avacta Group Market Cap?
As of today, Avacta Group market cap is 261.53M.
What is Avacta Group Earnings Per Share?
The Avacta Group EPS is -0.091.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.